| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |